Tag: ribonucleic acid (rna) sequencing market analysis

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Ribonucleic Acid (RNA) Sequencing Market from 2024 to 2033?
The ribonucleic acid (RNA) sequencing market has expanded significantly in recent years. It is expected to grow from $2.66 billion in 2023 to $7.29 billion in 2024, achieving a CAGR of 22.2%. Growth factors include an increase in drug development efforts, a rise in genetic disorders, greater use of portable instruments, biomarker profiling, demand for personalized medicine, and a growing cancer patient population.

The ribonucleic acid (RNA) sequencing market is expected to reach $7.29 billion by 2028 with a CAGR of 22.4%. The growth is attributed to the rising demand for rapid and accurate disease diagnosis, growing adoption of real-time polymerase chain reaction, and the need for on-site diagnostic testing. Key trends include disease detection and monitoring, drug discovery, biomarker identification, next-generation sequencing, and advancements in molecular diagnostics.

Claim Your Free Sample of the Global Ribonucleic Acid (RNA) Sequencing Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15665&type=smp

What Key Factors Are Fueling the Growth of the Ribonucleic Acid (RNA) Sequencing Market?
An increasing focus on precision medicine is expected to propel the growth of the ribonucleic acid (RNA) sequencing market going forward. Precision medicine or personalized medicine is an innovative approach to medical treatment and prevention that considers individual variability in genes, environment, and lifestyle for each person. Personalized medicine has the potential to provide more effective treatments, advancements in genomics, increasing disease complexity, and regulatory support. RNA sequencing technologies are utilized to determine the sequence and quantify the expression levels of RNA molecules within a sample. It enables comprehensive analysis of transcriptomes and insights into gene expression patterns, alternative splicing events, and RNA modifications. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, increasing focus on precision medicine drives the ribonucleic acid (RNA) sequencing market.

What Are the Major Segments of the Ribonucleic Acid (RNA) Sequencing Market?
1) By Product Type: Instruments; Reagents And Kits; Software
2) By Technology: Single Molecule Based Sequencing; Sequence By Synthesis Technology; Nanopore Sequencing Technology; Ion Torrent Semiconductor Sequencing
3) By Applications: Diagnostics; Drug Discovery; Translational Medicine; Other Applications
4) By End User: Research And Academia; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users

What New Trends Are Transforming the Ribonucleic Acid (RNA) Sequencing Market?
Major firms in the ribonucleic acid (RNA) sequencing market are enhancing patient care through RNA next-generation sequencing assays. Tempus launched the Tempus xR assay in June 2023, providing comprehensive analysis of solid tumors, including significant gene fusions.

Order Now for Fast Delivery of Your Ribonucleic Acid (RNA) Sequencing Market Report!
https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report

Which Regions Are Driving Growth in the Ribonucleic Acid (RNA) Sequencing Market?
North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period.  The regions covered in the ribonucleic acid (RNA) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Ribonucleic Acid (RNA) Sequencing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the ribonucleic acid (rna) sequencing market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Ribonucleic Acid (RNA) Sequencing Market Include

1. Ribonucleic Acid (RNA) Sequencing Market Executive Summary
2. Ribonucleic Acid (RNA) Sequencing Market Segments
3. Ribonucleic Acid (RNA) Sequencing Market Size And Template Market Growth Rate
4.  Key Ribonucleic Acid (RNA) Sequencing Market Trends
5. Major Ribonucleic Acid (RNA) Sequencing Market Drivers
……
25. Key Mergers And Acquisitions In The Ribonucleic Acid (RNA) Sequencing Market
26. Top Ribonucleic Acid (RNA) Sequencing Companies
27. Ribonucleic Acid (RNA) Sequencing Market Opportunities And Strategies
28. Ribonucleic Acid (RNA) Sequencing Market, Conclusions And Recommendations
29. Appendix

Discover Related Reports by The Business Research Company:
Induction Furnace Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/induction-furnace-global-market-report

Alternative Fuel Vehicles Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/alternative-fuel-vehicles-global-market-report

NGS-Based RNA-Sequencing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Ribonucleic Acid (RNA) Sequencing Global Market Report 2023, the ribonucleic acid (RNA) sequencing market is expected to show significant growth in the forecast period.

• Rapid Market Expansion: The RNA sequencing market is set to grow from $2.66 billion in 2023 to $7.29 billion by 2024, reflecting a remarkable CAGR of 22.2%.
• Key Growth Factors: This surge is driven by increased drug development, a rise in genetic disorders, the adoption of portable instruments, and a growing demand for personalized medicine.
• Healthcare Evolution: The market’s growth is also fueled by an increase in cancer cases, leading to a higher demand for advanced diagnostic solutions.

Future Growth Projections

• Continued Market Expansion: By 2028, the RNA sequencing market is expected to reach $7.29 billion, with a CAGR of 22.4%.
• Emerging Trends: The market’s future growth will be propelled by the rising demand for rapid, accurate disease diagnosis and real-time PCR technologies.
• Technological Innovations: Key trends include advancements in next-generation sequencing (NGS), microfluidics, and lab-on-a-chip platforms, which are revolutionizing disease detection and drug discovery.

View More On The Ribonucleic Acid (RNA) Sequencing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report

Precision Medicine’s Impact on RNA Sequencing

• Personalized Treatment: Precision medicine, which tailors treatments based on individual genetic profiles, is a major driver of the RNA sequencing market.
• Genomic Advancements: RNA sequencing enables comprehensive analysis of gene expression patterns, RNA modifications, and alternative splicing events.
• Regulatory Support: The FDA’s approval of 16 novel personalized therapies in 2023 highlights the growing focus on precision medicine.

Leading Companies in the RNA Sequencing Market

• Industry Giants: Major players include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, and Merck KGaA.
• Technological Leaders: Companies like Illumina Inc., Agilent Technologies Inc., and GE HealthCare Technologies Inc. are at the forefront of innovation in RNA sequencing technologies.
• Broad Market Presence: These companies are instrumental in driving advancements in biomarker identification, drug discovery, and diagnostic testing.

Innovation Through Automation

• Next-Gen Sequencing: Companies are increasingly focusing on RNA next-generation sequencing (NGS) assays to improve patient care through precision medicine.
• Case Study – Tempus xR: In June 2023, Tempus introduced the Tempus xR assay, a cutting-edge NGS platform for solid tumors that offers comprehensive transcriptome analysis.
• Targeted Solutions: This assay caters to specific needs in RNA fusions and altered splicing, benefiting physicians, researchers, and biopharma companies.

Strategic Acquisitions Driving Market Growth

• M&A Activity: In January 2024, Parse Biosciences acquired Biomage, a UK-based RNA sequencing and analysis software company.
• Integration of Technologies: This acquisition allows Parse Biosciences to enhance its Evercode combinatorial barcoding technology with Biomage’s advanced data analysis tools.
• Market Impact: Such strategic moves are crucial for companies to stay competitive and innovate in the rapidly growing RNA sequencing market.

Regional Insights

• Market Leaders: North America was the largest region in the RNA sequencing market in 2023, driven by advanced healthcare infrastructure and technological innovation.
• Rapid Growth in Asia-Pacific: The Asia-Pacific region is expected to be the fastest-growing market during the forecast period, owing to increasing healthcare investments and rising demand for advanced diagnostic technologies.

Conclusion

The RNA sequencing market is experiencing exponential growth, driven by technological advancements, the rise of precision medicine, and strategic acquisitions. As major players continue to innovate and expand their capabilities, the market is poised for continued success, with significant opportunities in diagnostics, drug discovery, and personalized medicine.

Request A Sample Of The Global Ribonucleic Acid (RNA) Sequencing Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15665&type=smp